May 2012

Pre-Clinical Data Demonstrates Promising Potential of MannKind’s IRE1α Inhibitor to Treat Multiple Myeloma
Pre-Clinical Data Demonstrates Promising Potential of MannKind’s IRE1α Inhibitor to Treat Multiple Myeloma
Yahoo
MannKind
IRE1α inhibitor
MKC-3946
Multiple Myeloma
Sanofi Aims To Be Pharma’s Top R&D Organization, Zerhouni Says
Sanofi Aims To Be Pharma’s Top R&D Organization, Zerhouni Says
Bloomberg
R&D
Sanofi
BioMarin to Raise Funds
BioMarin to Raise Funds
Yahoo/Zacks
Biomarin
stock offering
Human Genome Sciences Takeover Defense Survives Court Test
Human Genome Sciences Takeover Defense Survives Court Test
Bloomberg
Human Genome Sciences
GSK
M&A
hostile bid
New Drug Could Be Game Changer For Sanofi
New Drug Could Be Game Changer For Sanofi
Seeking Alpha
Sanofi
liver cancer
GSK
AstraZeneca
Bristol-Myers Squibb
No Good News for Waiting Chelsea Investors
No Good News for Waiting Chelsea Investors
Motley Fool
Chelsea Therapeutics
Northera
CH-4051
rheumatoid arthritis
The Drug Works, but Is It Worth Proceeding?
The Drug Works, but Is It Worth Proceeding?
Motley Fool
Alnylam
ALN-RSV01
Medivation Emerges With New Prostate Cancer Drug
Medivation Emerges With New Prostate Cancer Drug
Xconomy
Medivation
prostate cancer
MDV3100
Astellas
Teva Begins Trading on the New York Stock Exchange
Teva Begins Trading on the New York Stock Exchange
Yahoo
Teva Pharmaceuticals
NYSE
Icahn nominates new directors to Forest Labs board
Icahn nominates new directors to Forest Labs board
Yahoo/AP
Carl Icahn
Forest Labs

Pages